Indiana University Research & Technology Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Indiana University Research & Technology Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11479
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Indiana University Research & Technology Corp (IURTC), a subsidiary of Indiana University, is a non-profit company that handles intellectual property, trademarks, and business development activities. The company offers solutions such as technology commercialization, which include disclosure, marketing, legal protection and evaluation of research discoveries; and software licensing. IURTC provides services to entrepreneurs to start up a new business through experienced partners help with business planning, attracting investors, and marketing. The company collaborates with companies in technology, the life sciences, and manufacturing sectors. IURTC is headquartered in Indianapolis, Indiana, the US.

Indiana University Research & Technology Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Indiana University Research & Technology Corp, Medical Devices Deals, 2012 to YTD 2018 9
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Apexian Pharma Enters into Licensing Agreement with Indiana University Research and Technology 11
Chondrial Therapeutics Enters into Licensing Agreement with Indiana University Research & Technology and Wake Forest University Health Sciences 12
Spotlight Innovation Enters into Licensing Agreement with Indiana University Research & Technology 13
IURTC Enters into Licensing Agreement with La Jolla Pharma 14
IURTC and University of Alabama at Birmingham Enter into Licensing Agreement with La Jolla Pharma 15
Apexian Pharma Enters into Licensing Agreement with Indiana University 16
Cellular Dynamics International Enters into Licensing Agreement with IURTC 17
Assembly Pharma Enters into Licensing Agreement with IURTC 18
Asset Transactions 19
La Jolla Pharma to Acquire Rights to Gentamicin Derivatives from IURTC 19
Indiana University Research & Technology Corp – Key Employees 20
Indiana University Research & Technology Corp – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Key Facts 2
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indiana University Research & Technology Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Indiana University Research & Technology Corp, Medical Devices Deals, 2012 to YTD 2018 9
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Apexian Pharma Enters into Licensing Agreement with Indiana University Research and Technology 11
Chondrial Therapeutics Enters into Licensing Agreement with Indiana University Research & Technology and Wake Forest University Health Sciences 12
Spotlight Innovation Enters into Licensing Agreement with Indiana University Research & Technology 13
IURTC Enters into Licensing Agreement with La Jolla Pharma 14
IURTC and University of Alabama at Birmingham Enter into Licensing Agreement with La Jolla Pharma 15
Apexian Pharma Enters into Licensing Agreement with Indiana University 16
Cellular Dynamics International Enters into Licensing Agreement with IURTC 17
Assembly Pharma Enters into Licensing Agreement with IURTC 18
La Jolla Pharma to Acquire Rights to Gentamicin Derivatives from IURTC 19
Indiana University Research & Technology Corp, Key Employees 20

List of Figures
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indiana University Research & Technology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Indiana University Research & Technology Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Indiana University Research & Technology Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Edge Therapeutics Inc (EDGE):企業の財務・戦略的SWOT分析
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neuro …
  • National Instruments Corp (NATI):企業の財務・戦略的SWOT分析
    National Instruments Corp (NATI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • STRATA Skin Sciences Inc (SSKN):企業の財務・戦略的SWOT分析
    STRATA Skin Sciences Inc (SSKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Cara Therapeutics Inc (CARA):製薬・医療:M&Aディール及び事業提携情報
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • BAE Systems Inc:企業の戦略・SWOT・財務情報
    BAE Systems Inc - Strategy, SWOT and Corporate Finance Report Summary BAE Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Iroko Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Iroko Pharmaceuticals LLC (Iroko) is a pharmaceutical company that develops treatment options for responsible pain management. The company’s products comprise low dose Nonsteroidal anti-inflammatory drugs such as meloxicam, indomethacin, and diclofenac that are in various stages of nonclinic …
  • Esselte Corporation:企業の戦略・SWOT・財務分析
    Esselte Corporation - Strategy, SWOT and Corporate Finance Report Summary Esselte Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Aleva Neurotherapeutics SA:医療機器:M&Aディール及び事業提携情報
    Summary Aleva Neurotherapeutics SA (Aleva) is a medical device company that provides neuro-stimulation solutions. The company’s products include deep brain stimulation diagnostic systems and deep brain stimulation systems. Its deep brain stimulation systems provide directional stimulation for more p …
  • TIVIT Terceirizacao de Tecnologia e Servicos SA:企業の戦略的SWOT分析
    TIVIT Terceirizacao de Tecnologia e Servicos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Sanquin Blood Supply Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, an …
  • Galderma SA:企業の戦略的SWOT分析
    Galderma SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft:企業の戦略・SWOT・財務情報
    Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers th …
  • JEA:発電所・企業SWOT分析
    JEA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), a …
  • MetaStat Inc (MTST)-製薬・医療分野:企業M&A・提携分析
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • SiteOne Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary SiteOne Therapeutics Inc (SiteOne) is a developer of novel therapeutics and diagnostics for the treatment of acute and chronic pain. The company’s lead therapeutic candidates comprise selective inhibitors of a voltage-gated sodium ion channel, Na 1.7 which helps to generate and conduct pain …
  • EnerSys (ENS):企業の財務・戦略的SWOT分析
    EnerSys (ENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • American Outdoor Brands Corp:企業の戦略・SWOT・財務情報
    American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report Summary American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lantheus Medical Imaging Inc:企業の戦略的SWOT分析
    Lantheus Medical Imaging Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Abu Dhabi Water & Electricity Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Water & Electricity Authority (ADWEA) is a government-owned organization provides utility services. The authority researches and develops methods for the production, distribution and consumption of water and electricity efficiently. Through subsidiaries, ADWEA conducts generation, …
  • Therapeutic Solutions International Inc (TSOI)-医療機器分野:企業M&A・提携分析
    Summary Therapeutic Solutions International Inc (Therapeutic Solutions) is a pharmaceutical company that provides supplement products. The company offers ProJuvenol, T-Rx and Vital. Its ProJuvenol consists of anti-aging ingredients which helps for a healthy functionality for everyday living and prom …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆